Scrubs to Stilettos · 21 May 2026 · 51 min
Listen at the source: Dr. Tiffany Moon & Dr. Nicole Martin ↗ · audio
This week on Scrubs to Stilettos, we’re talking about libido, power, policy — and why women’s sexual health has historically been treated so differently than men’s. We’re joined by Cindy Eckert, founder and CEO of Sprout Pharmaceuticals and the force behind Addyi — the first FDA-approved treatment for hypoactive sexual desire disorder (HSDD) in women, often referred to as the “female viagra” or “little pink pill.” Cindy opens up about the uphill battle to bring Addyi to market, the gender bias she says exists in medicine and regulation, and why women’s desire has been misunderstood for so long. We also discuss the landmark FDA expansion approving Addyi for postmenopausal women and what this moment means for the future of women’s health. Plus, Cindy shares what it was like seeing her story documented in The Pink Pill: Sex, Drugs, and Who Has Control, which premiered March 6 on Paramount+.
As published with the episode at Scrubs to Stilettos ↗
No summary of this episode yet.